Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1995 Jan;69(1):395–402. doi: 10.1128/jvi.69.1.395-402.1995

Negative regulation of the bovine papillomavirus E5, E6, and E7 oncogenes by the viral E1 and E2 genes.

S B Vande Pol 1, P M Howley 1
PMCID: PMC188587  PMID: 7983735

Abstract

Papillomaviruses induce benign squamous epithelial lesions that infrequently are associated with uncontrolled growth or malignant conversion. The virus-encoded oncogenes are clearly under negative regulation since papillomaviruses can latently infect cells and since different levels of viral oncogene expression are seen within the layers of differentiating infected epitheliomas. We used bovine papillomavirus type 1 (BPV-1) to investigate the mechanisms involved in the negative regulation of transformation. We found that the following two distinct and interacting mechanisms negatively regulate BPV-1 transformation effected by virally encoded trans-acting factors: (i) E2 repressors suppress transformation by the E6 and E7 oncogenes, and (ii) E1 and the E2 transactivator suppress transformation by the E6, E7, and E5 oncogenes. These systems interact in that the E2 repressors function to relieve the transformation suppression effected by the E1 and E2 transactivator genes. A BPV-1 mutant that lacked E2 repressors and E1 had greatly augmented transformation capacity. Analysis of this mutant revealed that the enhanced transformation was due to expression of the E6 and E7 genes in the absence of E5, revealing a previously unappreciated potency and synergy for the BPV-1 E6 and E7 oncogenes.

Full Text

The Full Text of this article is available as a PDF (420.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer T. K., Lefebvre P., Wolford R. G., Hager G. L. Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science. 1992 Mar 20;255(5051):1573–1576. doi: 10.1126/science.1347958. [DOI] [PubMed] [Google Scholar]
  2. Askew D. S., Ashmun R. A., Simmons B. C., Cleveland J. L. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. 1991 Oct;6(10):1915–1922. [PubMed] [Google Scholar]
  3. Barksdale S. K., Baker C. C. Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters. J Virol. 1993 Sep;67(9):5605–5616. doi: 10.1128/jvi.67.9.5605-5616.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barsoum J., Prakash S. S., Han P., Androphy E. J. Mechanism of action of the papillomavirus E2 repressor: repression in the absence of DNA binding. J Virol. 1992 Jun;66(6):3941–3945. doi: 10.1128/jvi.66.6.3941-3945.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bell S. P., Kobayashi R., Stillman B. Yeast origin recognition complex functions in transcription silencing and DNA replication. Science. 1993 Dec 17;262(5141):1844–1849. doi: 10.1126/science.8266072. [DOI] [PubMed] [Google Scholar]
  6. Bergman P., Ustav M., Sedman J., Moreno-Lopéz J., Vennström B., Pettersson U. The E5 gene of bovine papillomavirus type 1 is sufficient for complete oncogenic transformation of mouse fibroblasts. Oncogene. 1988 May;2(5):453–459. [PubMed] [Google Scholar]
  7. Blitz I. L., Laimins L. A. The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro. J Virol. 1991 Feb;65(2):649–656. doi: 10.1128/jvi.65.2.649-656.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boshart M., Gissmann L., Ikenberg H., Kleinheinz A., Scheurlen W., zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 1984 May;3(5):1151–1157. doi: 10.1002/j.1460-2075.1984.tb01944.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brandsma J. L., Yang Z. H., Barthold S. W., Johnson E. A. Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4816–4820. doi: 10.1073/pnas.88.11.4816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chen L. P., Thomas E. K., Hu S. L., Hellström I., Hellström K. E. Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):110–114. doi: 10.1073/pnas.88.1.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chen L., Ashe S., Brady W. A., Hellström I., Hellström K. E., Ledbetter J. A., McGowan P., Linsley P. S. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 1992 Dec 24;71(7):1093–1102. doi: 10.1016/s0092-8674(05)80059-5. [DOI] [PubMed] [Google Scholar]
  12. Chiang C. M., Broker T. R., Chow L. T. Properties of bovine papillomavirus E1 mutants. Virology. 1992 Dec;191(2):964–967. doi: 10.1016/0042-6822(92)90273-r. [DOI] [PubMed] [Google Scholar]
  13. Choe J., Vaillancourt P., Stenlund A., Botchan M. Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs. J Virol. 1989 Apr;63(4):1743–1755. doi: 10.1128/jvi.63.4.1743-1755.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. DiMaio D., Guralski D., Schiller J. T. Translation of open reading frame E5 of bovine papillomavirus is required for its transforming activity. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1797–1801. doi: 10.1073/pnas.83.6.1797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dürst M., Kleinheinz A., Hotz M., Gissmann L. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol. 1985 Jul;66(Pt 7):1515–1522. doi: 10.1099/0022-1317-66-7-1515. [DOI] [PubMed] [Google Scholar]
  16. Evan G. I., Wyllie A. H., Gilbert C. S., Littlewood T. D., Land H., Brooks M., Waters C. M., Penn L. Z., Hancock D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992 Apr 3;69(1):119–128. doi: 10.1016/0092-8674(92)90123-t. [DOI] [PubMed] [Google Scholar]
  17. Gloss B., Bernard H. U. The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol. 1990 Nov;64(11):5577–5584. doi: 10.1128/jvi.64.11.5577-5584.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hansen U., Tenen D. G., Livingston D. M., Sharp P. A. T antigen repression of SV40 early transcription from two promoters. Cell. 1981 Dec;27(3 Pt 2):603–613. doi: 10.1016/0092-8674(81)90402-5. [DOI] [PubMed] [Google Scholar]
  19. Hermonat P. L., Howley P. M. Mutational analysis of the 3' open reading frames and the splice junction at nucleotide 3225 of bovine papillomavirus type 1. J Virol. 1987 Dec;61(12):3889–3895. doi: 10.1128/jvi.61.12.3889-3895.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Howes K. A., Ransom N., Papermaster D. S., Lasudry J. G., Albert D. M., Windle J. J. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev. 1994 Jun 1;8(11):1300–1310. doi: 10.1101/gad.8.11.1300. [DOI] [PubMed] [Google Scholar]
  21. Howley P. M., Schlegel R. The human papillomaviruses. An overview. Am J Med. 1988 Aug 29;85(2A):155–158. [PubMed] [Google Scholar]
  22. Hubert W. G., Lambert P. F. The 23-kilodalton E1 phosphoprotein of bovine papillomavirus type 1 is nonessential for stable plasmid replication in murine C127 cells. J Virol. 1993 May;67(5):2932–2937. doi: 10.1128/jvi.67.5.2932-2937.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lambert P. F., Howley P. M. Bovine papillomavirus type 1 E1 replication-defective mutants are altered in their transcriptional regulation. J Virol. 1988 Nov;62(11):4009–4015. doi: 10.1128/jvi.62.11.4009-4015.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lambert P. F., Monk B. C., Howley P. M. Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants. J Virol. 1990 Feb;64(2):950–956. doi: 10.1128/jvi.64.2.950-956.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lambert P. F., Spalholz B. A., Howley P. M. A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator. Cell. 1987 Jul 3;50(1):69–78. doi: 10.1016/0092-8674(87)90663-5. [DOI] [PubMed] [Google Scholar]
  26. McBride A. A., Byrne J. C., Howley P. M. E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. Proc Natl Acad Sci U S A. 1989 Jan;86(2):510–514. doi: 10.1073/pnas.86.2.510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. McBride A. A., Romanczuk H., Howley P. M. The papillomavirus E2 regulatory proteins. J Biol Chem. 1991 Oct 5;266(28):18411–18414. [PubMed] [Google Scholar]
  28. Meneguzzi G., Cerni C., Kieny M. P., Lathe R. Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. Virology. 1991 Mar;181(1):62–69. doi: 10.1016/0042-6822(91)90470-v. [DOI] [PubMed] [Google Scholar]
  29. Mohr I. J., Clark R., Sun S., Androphy E. J., MacPherson P., Botchan M. R. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science. 1990 Dec 21;250(4988):1694–1699. doi: 10.1126/science.2176744. [DOI] [PubMed] [Google Scholar]
  30. Neary K., DiMaio D. Open reading frames E6 and E7 of bovine papillomavirus type 1 are both required for full transformation of mouse C127 cells. J Virol. 1989 Jan;63(1):259–266. doi: 10.1128/jvi.63.1.259-266.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Pan H., Griep A. E. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 1994 Jun 1;8(11):1285–1299. doi: 10.1101/gad.8.11.1285. [DOI] [PubMed] [Google Scholar]
  32. Prakash S. S., Horwitz B. H., Zibello T., Settleman J., DiMaio D. Bovine papillomavirus E2 gene regulates expression of the viral E5 transforming gene. J Virol. 1988 Oct;62(10):3608–3613. doi: 10.1128/jvi.62.10.3608-3613.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rabson M. S., Yee C., Yang Y. C., Howley P. M. Bovine papillomavirus type 1 3' early region transformation and plasmid maintenance functions. J Virol. 1986 Nov;60(2):626–634. doi: 10.1128/jvi.60.2.626-634.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Riese D. J., 2nd, Settleman J., Neary K., DiMaio D. Bovine papillomavirus E2 repressor mutant displays a high-copy-number phenotype and enhanced transforming activity. J Virol. 1990 Feb;64(2):944–949. doi: 10.1128/jvi.64.2.944-949.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Romanczuk H., Howley P. M. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3159–3163. doi: 10.1073/pnas.89.7.3159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rotenberg M. O., Chow L. T., Broker T. R. Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction. Virology. 1989 Oct;172(2):489–497. doi: 10.1016/0042-6822(89)90191-8. [DOI] [PubMed] [Google Scholar]
  37. Sandler A. B., Vande Pol S. B., Spalholz B. A. Repression of bovine papillomavirus type 1 transcription by the E1 replication protein. J Virol. 1993 Sep;67(9):5079–5087. doi: 10.1128/jvi.67.9.5079-5087.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sang B. C., Barbosa M. S. Increased E6/E7 transcription in HPV 18-immortalized human keratinocytes results from inactivation of E2 and additional cellular events. Virology. 1992 Aug;189(2):448–455. doi: 10.1016/0042-6822(92)90568-a. [DOI] [PubMed] [Google Scholar]
  39. Sarver N., Rabson M. S., Yang Y. C., Byrne J. C., Howley P. M. Localization and analysis of bovine papillomavirus type 1 transforming functions. J Virol. 1984 Nov;52(2):377–388. doi: 10.1128/jvi.52.2.377-388.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Scheffner M., Romanczuk H., Münger K., Huibregtse J. M., Mietz J. A., Howley P. M. Functions of human papillomavirus proteins. Curr Top Microbiol Immunol. 1994;186:83–99. doi: 10.1007/978-3-642-78487-3_5. [DOI] [PubMed] [Google Scholar]
  41. Schiller J. T., Kleiner E., Androphy E. J., Lowy D. R., Pfister H. Identification of bovine papillomavirus E1 mutants with increased transforming and transcriptional activity. J Virol. 1989 Apr;63(4):1775–1782. doi: 10.1128/jvi.63.4.1775-1782.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Schwarz E., Freese U. K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985 Mar 7;314(6006):111–114. doi: 10.1038/314111a0. [DOI] [PubMed] [Google Scholar]
  43. Spalholz B. A. Importance of the bovine papillomavirus P2443 promoter in the regulation of E2 and E5 expression. J Virol. 1993 Oct;67(10):6278–6284. doi: 10.1128/jvi.67.10.6278-6284.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Spalholz B. A., McBride A. A., Sarafi T., Quintero J. Binding of bovine papillomavirus E1 to the origin is not sufficient for DNA replication. Virology. 1993 Mar;193(1):201–212. doi: 10.1006/viro.1993.1116. [DOI] [PubMed] [Google Scholar]
  45. Stewart A. C., Burnett S. Anomalous transforming behavior of a bovine papillomavirus type 1 mutant with an upstream promoter mutation. J Virol. 1994 Jul;68(7):4669–4672. doi: 10.1128/jvi.68.7.4669-4672.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Stoler M. H., Whitbeck A., Wolinsky S. M., Broker T. R., Chow L. T., Howett M. K., Kreider J. W. Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice. J Virol. 1990 Jul;64(7):3310–3318. doi: 10.1128/jvi.64.7.3310-3318.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Subramanian T., Tarodi B., Govindarajan R., Boyd J. M., Yoshida K., Chinnadurai G. Mutational analysis of the transforming and apoptosis suppression activities of the adenovirus E1B 175R protein. Gene. 1993 Feb 28;124(2):173–181. doi: 10.1016/0378-1119(93)90391-f. [DOI] [PubMed] [Google Scholar]
  48. Syrjänen S., Saastamoinen J., Chang F. J., Ji H. X., Syrjänen K. Colposcopy, punch biopsy, in situ DNA hybridization, and the polymerase chain reaction in searching for genital human papillomavirus (HPV) infections in women with normal PAP smears. J Med Virol. 1990 Aug;31(4):259–266. doi: 10.1002/jmv.1890310404. [DOI] [PubMed] [Google Scholar]
  49. Thierry F., Yaniv M. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J. 1987 Nov;6(11):3391–3397. doi: 10.1002/j.1460-2075.1987.tb02662.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Thorner L., Bucay N., Choe J., Botchan M. The product of the bovine papillomavirus type 1 modulator gene (M) is a phosphoprotein. J Virol. 1988 Jul;62(7):2474–2482. doi: 10.1128/jvi.62.7.2474-2482.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ustav M., Stenlund A. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 1991 Feb;10(2):449–457. doi: 10.1002/j.1460-2075.1991.tb07967.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Ustav M., Ustav E., Szymanski P., Stenlund A. Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J. 1991 Dec;10(13):4321–4329. doi: 10.1002/j.1460-2075.1991.tb05010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Vande Pol S. B., Howley P. M. The bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latency. J Virol. 1992 Apr;66(4):2346–2358. doi: 10.1128/jvi.66.4.2346-2358.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. White E., Cipriani R., Sabbatini P., Denton A. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J Virol. 1991 Jun;65(6):2968–2978. doi: 10.1128/jvi.65.6.2968-2978.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wilson V. G., Ludes-Meyers J. A bovine papillomavirus E1-related protein binds specifically to bovine papillomavirus DNA. J Virol. 1991 Oct;65(10):5314–5322. doi: 10.1128/jvi.65.10.5314-5322.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wyllie A. H., Rose K. A., Morris R. G., Steel C. M., Foster E., Spandidos D. A. Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br J Cancer. 1987 Sep;56(3):251–259. doi: 10.1038/bjc.1987.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Yang L., Mohr I., Li R., Nottoli T., Sun S., Botchan M. Transcription factor E2 regulates BPV-1 DNA replication in vitro by direct protein-protein interaction. Cold Spring Harb Symp Quant Biol. 1991;56:335–346. doi: 10.1101/sqb.1991.056.01.040. [DOI] [PubMed] [Google Scholar]
  58. Zemlo T. R., Lohrbach B., Lambert P. F. Role of transcriptional repressors in transformation by bovine papillomavirus type 1. J Virol. 1994 Oct;68(10):6787–6793. doi: 10.1128/jvi.68.10.6787-6793.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Zhang S., Mak S., Branton P. E. Overexpression of the E1B 55-kilodalton (482R) protein of human adenovirus type 12 appears to permit efficient transformation of primary baby rat kidney cells in the absence of the E1B 19-kilodalton protein. J Virol. 1992 Apr;66(4):2302–2309. doi: 10.1128/jvi.66.4.2302-2309.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES